Senior Consultant
National University Cancer Institute, Singapore, United States
Professor Wee Joo Chng is a Yong Loo Lin Professor in Medical Oncology and Vice Dean of Research at the Yong Loo Lin School of Medicine, National University of Singapore, where he is also a Senior Principal Investigator at the Cancer Science Institute of Singapore. He is a Senior Consultant at the National University Cancer Institute, Singapore and the Group Director of Research, at the National University Health System.
Professor Chng currently serves as Executive Director of the Singapore Translational Cancer Consortium. His research focuses on understanding the biology of high risk myeloma using multi-omics approaches and also clinical trials in myeloma.
Professor Chng is a member of many international professional committees, such as the International Myeloma Working Group and the Asian Myeloma Network. He is also involved in a number of Grant Review Committees, Conference Organising Committees, Advisory Boards and the Steering Committees of Global Clinical Trials. He has authored more than 350 publications in many reputed journals, and actively participates in clinical trials, and has delivered talks at many national and international conferences. He has won multiple awards for his outstanding achievements in translational research both locally and internationally including the NUHS Research Excellence Award, the International Myeloma Foundation’s Brian GM Durie Outstanding Achievement Award, the National Medical Excellence Outstanding Clinician Scientist Award, the National Medical Research Council Senior Translational Research (STaR) Award, the National University of Singapore Young Researcher Award, and the Celgene Future Leaders in Haematology Award.
Disclosure information not submitted.
Other factors for identification of high risk beyond cytogenetic
Thursday, September 26, 2024
9:10 AM – 9:20 AM East Coast USA Time
Thursday, September 26, 2024
10:00 AM – 10:30 AM East Coast USA Time